First report of the emergence of CTX-M-Type extended-spectrum β-lactamases (ES-BLs) as the predominant ESBL isolated in a US health care Systemdel

被引:137
作者
Lewis, James S., II
Herrera, Monica
Wickes, Brian
Patterson, Jan E.
Jorgensen, James H.
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[2] Univ Hlth Syst, Dept Pharm, San Antonio, TX USA
[3] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78284 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA
关键词
D O I
10.1128/AAC.00576-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CTX-M-type extended-spectrum beta-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in Escherichia coli isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing E. coli, which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing Klebsiella spp. was not helpful with initial recognition. CTX-M enzymes were also identified in Proteus mirabilis, Enterobacter spp., and Morganella morganii. Based on pulsed-field gel electrophoresis typing of the E. coli isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.
引用
收藏
页码:4015 / 4021
页数:7
相关论文
共 23 条
[1]   Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital [J].
Ben-Ami, R ;
Schwaber, MJ ;
Navon-Venezia, S ;
Schwartz, D ;
Giladi, M ;
Chmelnitsky, I ;
Leavitt, A ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :925-934
[2]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[3]   Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York [J].
Bratu, Simona ;
Brooks, Steven ;
Burney, Sibte ;
Kochar, Sandeep ;
Gupta, Jyoti ;
Landman, David ;
Quale, John .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (07) :972-975
[4]   Clinical and microbiologic analysis of a hospital's extended-spectrum β-lactamase-producing isolates over a 2-year period [J].
Burgess, DS ;
Hall, RG ;
Lewis, JS ;
Jorgensen, JH ;
Patterson, JE .
PHARMACOTHERAPY, 2003, 23 (10) :1232-1237
[5]  
*CLIN LAB STAND I, 2007, M7A8 CLIN LAB STAND
[6]  
*CLIN LAB STAND I, 2007, M2A10 CLIN LAB STAND
[7]  
Clinical and laboratory Standards Institute, 2007, M100S17 CLSI
[8]   Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals [J].
Edelstein, M ;
Pimkin, M ;
Palagin, I ;
Edelstein, I ;
Stratchounski, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3724-3732
[9]   Extended-spectrum β-lactamases in multidrug-resistant Escherichia coli:: Changing the therapy for hospital-acquired and community-acquired infections [J].
Helfand, Marion S. ;
Bonomo, Robert A. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (11) :1415-1416
[10]   CTX-M: changing the face of ESBLs in Europe [J].
Livermore, David M. ;
Canton, Rafael ;
Gniadkowski, Marek ;
Nordmann, Patrice ;
Rossolini, Gian Maria ;
Arlet, Guillaume ;
Ayala, Juan ;
Coque, Teresa M. ;
Kern-Zdanowicz, Izabela ;
Luzzaro, Francesco ;
Poirel, Laurent ;
Woodford, Neil .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (02) :165-174